1 Department of Pathobiology and Biomedical Methodologies, Immunohaemathology and Transfusion Medicine Unit, University Hospital, University of Palermo, Italy 2 Department of Pathobiology and ...

Don’t wait to start.

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

UCLA researchers have discovered a previously unrecognized type of progenitor cell that, though rare in most regions of the human prostate, is found in uncommonly high numbers in inflamed areas of the ...

FDA approves prostate cancer imaging agent Even after adjustment, acute, chronic inflammation linked to lower PCa risk at two-year repeat biopsy. HealthDay News — Among men with a negative biopsy for ...

The presence of chronic inflammation in benign prostate tissue samples is associated with prostate cancer, especially high-grade disease, according to a study published online in Cancer Epidemiology, ...

When compared with Zytiga, Xtandi appeared to have a lower incidence of infection among men with prostate cancer, especially those under 70 years. The utilization of Xtandi (enzalutamide), compared ...

Please provide your email address to receive an email when new articles are posted on . Transperineal prostate cancer biopsies did not cause any infections in a randomized trial. U.S. and European ...